AGP Executive Report
Last update: 3 hours agoPharma Tariffs, Liechtenstein Included: The US Commerce Department says it will apply a 0% ad valorem tariff to certain “specialty” drugs and ingredients imported from India and 19 other jurisdictions, including Liechtenstein, even as a 100% tariff on covered patented pharma imports is set to start Sept. 29. The carve-out targets treatments for rare diseases, infertility, cell and gene therapies, antibody-drug conjugates, and animal pharmaceuticals, with components also covered. Trade & Industry Link: A separate report notes the exemption is tied to qualifying trade and security frameworks, meaning eligibility isn’t automatic. EFTA Deal Moves Through Brazil: Brazil has formally incorporated the Mercosur-EFTA free trade agreement; preferential tariffs for Switzerland and Liechtenstein depend on their internal procedures. Local Market Watch: Geely has entered Switzerland with three new energy models, with Emil Frey also acting as importer for Liechtenstein.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
